• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺铂类似物在人非小细胞肺癌和多细胞球体生长的神经母细胞瘤实验化疗中的相对疗效。

The relative effectiveness of analogues of cisplatin in the experimental chemotherapy of human non-small-cell lung cancer and neuroblastoma grown as multicellular spheroids.

作者信息

Russell J, Adam J, Wheldon T E, Kaye S B

机构信息

Radiation Oncology Research Group, Beatson Oncology Centre, Belvidere Hospital, Glasgow, Scotland.

出版信息

Cancer Chemother Pharmacol. 1989;23(2):111-4. doi: 10.1007/BF00273527.

DOI:10.1007/BF00273527
PMID:2535968
Abstract

We compared cisplatin (cis-DDP) and two of its analogues, carboplatin (JM8, CBDCA) and iproplatin (JM9, CHIP) for their ability to retard the growth of multicellular tumour spheroids. The spheroids were derived from two human tumours, a neuroblastoma and a non-small-cell lung cancer. To produce a given level of regrowth delay in lung cancer spheroids, carboplatin and iproplatin were required at concentrations approximately 10 times that of cis-DDP. In the neuroblastoma spheroid experiments, iproplatin and cis-DDP produced the same level of regrowth delay when iproplatin was present at a concentration greater than 10 times that of cis-DDP. Carboplatin also required much higher concentrations than cis-DDP to produce equivalent regrowth delay in neuroblastoma. The dose-response curve produced by carboplatin on neuroblastoma spheroids displayed a pronounced shoulder in the low-dose region; this phenomenon was not seen with cis-DDP. These findings may have implications for the clinical use of these drugs and in particular would support a role for carboplatin in the treatment of lung cancer, since total free-drug exposure of patients to carboplatin may be up to 16-fold greater than with cis-DDP. However, one must be cautious about generalizing on the basis of results from only two cell lines as well as applying in vitro data to clinical situations.

摘要

我们比较了顺铂(顺式二氨基二氯铂)及其两种类似物卡铂(JM8,环丁二羧酸二氨合铂)和异丙铂(JM9,氯异柠檬酸铂)抑制多细胞肿瘤球体生长的能力。这些球体来源于两种人类肿瘤,一种是神经母细胞瘤,另一种是非小细胞肺癌。为了在肺癌球体中产生给定水平的再生长延迟,所需的卡铂和异丙铂浓度约为顺铂的10倍。在神经母细胞瘤球体实验中,当异丙铂的浓度大于顺铂浓度的10倍时,异丙铂和顺铂产生相同水平的再生长延迟。在神经母细胞瘤中,卡铂也需要比顺铂高得多的浓度才能产生等效的再生长延迟。卡铂对神经母细胞瘤球体产生的剂量反应曲线在低剂量区域显示出明显的平台期;顺铂未出现这种现象。这些发现可能对这些药物的临床应用有影响,特别是支持卡铂在肺癌治疗中的作用,因为患者对卡铂的总游离药物暴露量可能比顺铂高出多达16倍。然而,仅根据两种细胞系的结果进行概括以及将体外数据应用于临床情况时必须谨慎。

相似文献

1
The relative effectiveness of analogues of cisplatin in the experimental chemotherapy of human non-small-cell lung cancer and neuroblastoma grown as multicellular spheroids.顺铂类似物在人非小细胞肺癌和多细胞球体生长的神经母细胞瘤实验化疗中的相对疗效。
Cancer Chemother Pharmacol. 1989;23(2):111-4. doi: 10.1007/BF00273527.
2
Effectiveness of cis-platin and carboplatin in the chemotherapy of squamous cell carcinoma grown as multicellular spheroids.顺铂和卡铂在多细胞球体生长的鳞状细胞癌化疗中的有效性。
Anticancer Res. 1990 May-Jun;10(3):805-11.
3
Resistance and cross-resistance of the IgM immunocytoma in the LOU/M Wsl rat for cisplatin, carboplatin, and iproplatin.LOU/M Wsl大鼠中IgM免疫细胞瘤对顺铂、卡铂和异丙铂的耐药性及交叉耐药性。
Cancer Chemother Pharmacol. 1988;22(1):51-7. doi: 10.1007/BF00254181.
4
Comparison of the antitumor activity of cisplatin, carboplatin, and iproplatin against established human testicular cancer cell lines in vivo and in vitro.顺铂、卡铂和异丙铂对已建立的人睾丸癌细胞系的体内和体外抗肿瘤活性比较。
Cancer. 1989 Mar 15;63(6):1079-83. doi: 10.1002/1097-0142(19890315)63:6<1079::aid-cncr2820630607>3.0.co;2-j.
5
Resistance of in vitro grown IgM immunocytoma cells to cis-diamminedichloroplatinum (II) (cis-DDP) and cross-resistance to other DNA interacting drugs.体外培养的IgM免疫细胞瘤细胞对顺二氨二氯铂(II)(顺铂)的耐药性及对其他与DNA相互作用药物的交叉耐药性。
Anticancer Res. 1990 Mar-Apr;10(2A):447-52.
6
Cross resistance studies with L1210 leukemia subline single and double resistant to cisplatin and iproplatin (CHIP).对顺铂和异丙铂(CHIP)单耐药及双耐药的L1210白血病亚系进行交叉耐药研究。
Neoplasma. 1990;37(6):631-8.
7
Inhibition of pre-mRNA splicing by cisplatin and platinum analogs.顺铂及铂类类似物对前体mRNA剪接的抑制作用。
Int J Oncol. 2003 Sep;23(3):785-9.
8
[Pharmacological approach to the platinum compounds].[铂化合物的药理学方法]
Gan To Kagaku Ryoho. 1992 Apr;19(4):456-62.
9
Quantitative ultrastructural effects of cisplatin (Platinol), carboplatin (JM8), and iproplatin (JM9) on neurons of freshwater snail Lymnaea stagnalis.顺铂(铂尔定)、卡铂(JM8)和异环铂(JM9)对淡水蜗牛椎实螺神经元的定量超微结构影响
Cancer Res. 1992 Feb 15;52(4):963-73.
10
Cytotoxicity of cisplatin and cisdiammine-1,1-cyclobutane dicarboxylate in MGH-U1 cells grown as monolayers, spheroids, and xenografts.顺铂和顺二氨-1,1-环丁烷二羧酸盐对单层生长、球体生长和异种移植的MGH-U1细胞的细胞毒性。
J Natl Cancer Inst. 1985 Sep;75(3):499-505.

引用本文的文献

1
Comparison of the cytotoxic activities of cisplatin and carboplatin against glioma cell lines at pharmacologically relevant drug exposures.在药理学相关药物暴露水平下顺铂和卡铂对胶质瘤细胞系的细胞毒性活性比较。
J Neurooncol. 1991 Aug;11(1):27-35. doi: 10.1007/BF00166994.

本文引用的文献

1
Resistance to vincristine of human cells grown as multicellular spheroids.作为多细胞球体生长的人类细胞对长春新碱的耐药性。
Br J Cancer. 1980 Dec;42(6):937-41. doi: 10.1038/bjc.1980.344.
2
Limited penetration of methotrexate into human osteosarcoma spheroids as a proposed model for solid tumor resistance to adjuvant chemotherapy.甲氨蝶呤在人骨肉瘤球体中的渗透有限,这是实体瘤对辅助化疗耐药的一种模型。
Cancer Res. 1980 Oct;40(10):3665-8.
3
Pharmacokinetics of free platinum species following rapid, 3-hr and 24-hr infusions of cis-diamminedichloroplatinum (II) and its therapeutic implications.
顺二氨二氯铂(II)快速输注、3小时输注和24小时输注后游离铂物种的药代动力学及其治疗意义。
Eur J Cancer Clin Oncol. 1982 Nov;18(11):1069-74. doi: 10.1016/0277-5379(82)90085-2.
4
Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (CHIP) in patients with advanced cancer.顺二氯反二羟基双异丙胺铂(IV)(CHIP)在晚期癌症患者中的药代动力学
Cancer Chemother Pharmacol. 1983;11(1):23-8. doi: 10.1007/BF00257411.
5
Cell survival in four ovarian carcinoma xenografts following in vitro exposure to melphalan, cisplatin and cis-diammine-1,1-cyclobutane dicarboxylate platinum II (CBDCA,JM8).体外暴露于美法仑、顺铂和顺二氨-1,1-环丁烷二羧酸铂II(CBDCA,JM8)后四种卵巢癌异种移植瘤中的细胞存活情况。
Cancer Chemother Pharmacol. 1984;13(2):109-13. doi: 10.1007/BF00257125.
6
Phase II study of JM8, a new platinum analog, in advanced ovarian carcinoma.新型铂类类似物JM8用于晚期卵巢癌的II期研究。
Cancer Treat Rep. 1983 Nov;67(11):997-1000.
7
Effects of intercellular contact on repair of radiation damage.细胞间接触对辐射损伤修复的影响。
Exp Cell Res. 1972 Mar;71(1):75-80. doi: 10.1016/0014-4827(72)90265-0.
8
Activity of JM9 in advanced ovarian cancer: a phase I-II trial.JM9在晚期卵巢癌中的活性:一项I-II期试验。
Cancer Treat Rep. 1985 Apr;69(4):409-16.
9
Phase I studies with carboplatin at the Royal Marsden Hospital.皇家马斯登医院开展的卡铂一期研究。
Cancer Treat Rev. 1985 Sep;12 Suppl A:51-7. doi: 10.1016/0305-7372(85)90018-0.
10
Radiation studies on multicellular tumour spheroids derived from human neuroblastoma: absence of sparing effect of dose fractionation.源自人类神经母细胞瘤的多细胞肿瘤球体的放射研究:剂量分割无保护作用。
Eur J Cancer Clin Oncol. 1986 May;22(5):563-6. doi: 10.1016/0277-5379(86)90044-1.